Is immuno-oncology therapy effective in hypermutator glioblastomas with somatic or germline mutations?

被引：0
|
作者：
Kamiya-Matsuoka, C. [1 ]
Metrus, N. [1 ]
Weathers, S-P. [1 ]
Ross, J. [2 ]
Shaw, K. [3 ]
Penas-Prado, M. [4 ]
Loghin, M. [1 ]
Alfaro-Munoz, K. [1 ]
O'Brien, B. [1 ]
Harrison, R. [1 ]
Sadighi, Z. [5 ]
Majd, N. [1 ]
Yung, W. [1 ]
Meric-Bernstam, F. [6 ]
Hambardzumyan, D. [2 ]
de Groot, J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Neurooncol, Houston, TX 77030 USA
[2] Emory Univ, Sch Med, Pediat, Atlanta, GA USA
[3] Univ Texas MD Anderson Canc Ctr, Inst Personalized Canc Therapy, Houston, TX 77030 USA
[4] NIH, Neurooncol, Bldg 10, Bethesda, MD 20892 USA
[5] Univ Texas MD Anderson Canc Ctr, Pediat, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
393O
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [1] Immuno-oncology from the perspective of somatic evolution
    Gonzalez, Santiago
    Volkova, Nadezda
    Beer, Philip
    Gerstung, Moritz
    SEMINARS IN CANCER BIOLOGY, 2018, 52 : 75 - 85
  • [2] Repurposing Radiation Therapy for Immuno-oncology
    Tang, J.
    Malachowska, B.
    Wu, X.
    Guha, C.
    CLINICAL ONCOLOGY, 2021, 33 (11) : 683 - 693
  • [3] The revolution of immuno-oncology therapy: specificities for the physicians
    Dubois, Manon
    Ardin, Camille
    Andre, Fanny
    Scherpereel, Arnaud
    Mortier, Laurent
    M S-MEDECINE SCIENCES, 2020, 35 (12): : 937 - 945
  • [4] Novel strategies for immuno-oncology breakthroughs with cell therapy
    Hongtao Liu
    Chongxian Pan
    Wenru Song
    Delong Liu
    Zihai Li
    Lei Zheng
    Biomarker Research, 9
  • [5] Accurately identifying expressed somatic variants for neoantigen detection and immuno-oncology
    Boyle, Sean M.
    Clark, Michael J.
    Alla, Ravi
    Luo, Shujun
    Church, Deanna M.
    Heiman, Elena
    Sripakdeevong, Parin
    West, John
    Chen, Rich
    CANCER RESEARCH, 2016, 76
  • [6] Novel strategies for immuno-oncology breakthroughs with cell therapy
    Liu, Hongtao
    Pan, Chongxian
    Song, Wenru
    Liu, Delong
    Li, Zihai
    Zheng, Lei
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [7] Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast
    Vranic, Semir
    Senarathne, Wijendra
    Stafford, Phillip
    Poorman, Kelsey
    Pockaj, Barbara A.
    Gatalica, Zoran
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (09) : 661 - 668
  • [8] Advancing Cancer Therapy with Present and emerging immuno-Oncology Approaches
    Kamta, Jeff
    Chaar, Maher
    Ande, Anusha
    Altomare, Deborah A.
    Ait-Oudhia, Sihem
    Sharma, Sherven
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [9] Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
    Durham, Nicholas M.
    Mulgrew, Kathy
    McGlinchey, Kelly
    Monks, Noel R.
    Ji, Hong
    Herbst, Ronald
    Suzich, Joann
    Hammond, Scott A.
    Kelly, Elizabeth J.
    MOLECULAR THERAPY, 2017, 25 (08) : 1917 - 1932
  • [10] What Comes After Immuno-Oncology Therapy for Kidney Cancer?
    Zahoor, Haris
    Duddalwar, Vinay
    D'Souza, Anishka
    Merseburger, Axel S.
    Quinn, David, I
    KIDNEY CANCER, 2019, 3 (02) : 93 - 102
12345